Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress
Centogene N.V. - Common Shares (CNTG)
Last centogene n.v. - common shares earnings: 12/5 06:28 am
Check Earnings Report
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 23, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, announced today a corporate update and reported its financial results for the year ended December 31, 2019. €48.8 million in revenues, 21% increase compared to the year ended December 31, 2018, with approximately 51% growth in revenues in the fourth quarter ended December 31, 2019 as compared to the fourth quarter ended December 31, 201828 new pharmaceutical collaborations and 76 total active/completed collaborations as of December 31, 2019 with 39 pharmaceutical partners covering over 45 rare diseasesOver 133,000 order requests received in the year ended December 31, 2019, more than 27% increase as compared to the previous yearContinued expansion of global proprietary rare disease p
Show less
Read more
Impact Snapshot
Event Time:
CNTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNTG alerts
High impacting Centogene N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
CNTG
News
- CENTOGENE Receives Delisting Notice From Nasdaq [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Receives Delisting Notice From NasdaqGlobeNewswire
- CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic FactorsGlobeNewswire
- Europe Clinical Biomarkers Market Analysis and Forecast Report 2024, Featuring ALCEN, bioMerieux, Centogene, Eurofins Scientific, F. Hoffmann-La Roche and Qiagen [Yahoo! Finance]Yahoo! Finance
CNTG
Sec Filings
- 8/8/24 - Form 6-K
- 8/1/24 - Form 6-K
- CNTG's page on the SEC website